Sat.Nov 27, 2021 - Fri.Dec 03, 2021

article thumbnail

Hack targets Planned Parenthood, exposing personal information of 400K patients

Fierce Healthcare

Hack targets Planned Parenthood, exposing personal information of 400K patients. rtorrence. Fri, 12/03/2021 - 10:13.

145
145
article thumbnail

Digital health: the new normal?

pharmaphorum

Personalised and tailored healthcare that utilises patient’s data is rapidly becoming a reality. Ben Hargreaves looks at the concrete steps already being taken by companies in the area. Amongst the many ways in which the pandemic has changed the way in which we live, one of the most common experiences for most people was to revise what it means to have a face-to-face meeting.

145
145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Genetic testing offers powerful weapon for detecting breast cancer: Sema4

Outsourcing Pharma

A leader from the health tech solutions company explains how progress in genetic testing has helped advance the detection and prevention of breast cancer.

115
115
article thumbnail

GSK aim for HIV cure by 2030

Pharma Times

Following its recent approval of an injectable HIV-1 treatment from the National institute for Health and Care Excellence (NICE), GlaxoSmithKline (GSK) has high hopes in developing a cure for the virus in the future.

61
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

CVS inks tech partnership with Microsoft to accelerate its 'digital-first' strategy

Fierce Healthcare

CVS inks tech partnership with Microsoft to accelerate its 'digital-first' strategy. hlandi. Thu, 12/02/2021 - 06:26.

145
145
article thumbnail

Trial of Jazz’ cannabis drug in glioblastoma will start next year

pharmaphorum

An investigator-led trial of Jazz Pharma’s cannabis extract-based drug Sativex in glioblastoma – an aggressive form of brain cancer – will get underway in the UK next year. The three-year phase 2 trial will be carried out by researchers at Leeds University led by professor of clinical oncology and neuro-oncology Susan Short, and see if adding Sativex (nabiximols) to standard chemotherapy for recurrent glioblastoma can extend survival.

More Trending

article thumbnail

Late cancer diagnoses rise as NHS struggles with COVID-19

Pharma Times

Analyses provided by UK cancer charity Macmillan has provided insights into the repercussions experienced by patients waiting to receive treatment during the COVID-19 pandemic.

52
article thumbnail

Out-of-pocket costs may play larger role in telehealth visits than in-person care: survey

Fierce Healthcare

Out-of-pocket costs may play larger role in telehealth visits than in-person care: survey. rtorrence. Fri, 12/03/2021 - 16:07.

145
145
article thumbnail

Boehringer-backed digital health academy set for launch in UK

pharmaphorum

An online training academy that aims to raise the digital skills of NHS health and care workers is due to open its virtual doors next March, according to the Organisation for the Review of Care and Health Apps (ORCHA). The Digital Health Academy – developed with pharma company Boehringer Ingelheim – is part of a drive to get digital health tools and apps used more routinely in the management of health conditions, according to ORCHA.

121
121
article thumbnail

Decentralized format dramatically transforming clinical research: ICON

Outsourcing Pharma

An expert from the ]contract research organization discusses the impact virtual trials have had on the industry, and how that transformation is likely to continue.

104
104
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Possible identification of blood clot trigger for AstraZeneca COVID-19 vaccine

Pharma Times

Researchers have identified in those patients experiencing blood clots after vaccination a subsequent condition referred to as vaccine-induced immune thrombotic thrombocytopenia (VITT).

article thumbnail

Business Group: 6 health and wellness trends to watch in 2022

Fierce Healthcare

Business Group: 6 health and wellness trends to watch in 2022. pminemyer. Mon, 11/29/2021 - 12:17.

144
144
article thumbnail

MHRA okays GSK’s Xevudy as data suggest it works against Omicron

pharmaphorum

The UK medicines regulator has approved GlaxoSmithKline and Vir Biotech’s antibody for COVID-19, Xevudy, which has been shown to be effective against the new Omicron strain of SARS-CoV-2 in lab testing. Xevudy (sotrovimab) is the second COVID-19 antibody to be approved by the MHRA after Roche/Regeneron’s Ronapreve (casirivimab and imdevimab), which got a green light during the summer.

Vaccines 119
article thumbnail

GSK and University of Oxford launch new institute, embracing advanced technologies for drug discovery

Outsourcing Pharma

The Oxford-GSK Institute of Molecular and Computational Medicine has been created via a five-year collaboration between GlaxoSmithKline and the University of Oxford.

96
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Walking Each Other Home with Community-Based Psychedelic Support

The Spirit Pharmacist

Growing Pains and the Access Bottleneck. Psychedelic therapies are making headlines due to the unprecedented benefits demonstrated in clinical trials for persons with refractory mental illnesses. However, psychedelic assisted therapy is resource intensive and will likely come with a price tag putting it out of reach of many persons that could benefit from such therapies.

article thumbnail

Carbon Health launches new program with continuous glucose monitors to assess diabetes risk

Fierce Healthcare

Carbon Health launches new program with continuous glucose monitors to assess diabetes risk. rtorrence. Wed, 12/01/2021 - 17:47.

144
144
article thumbnail

AZ eyes FDA verdict on Lynparza in adjuvant breast cancer in Q1

pharmaphorum

The FDA will deliver a verdict on AstraZeneca’s PARP inhibitor Lynparza as an adjuvant treatment for breast cancer in the first quarter of next year, after granting the application a priority review. AZ and partner Merck & Co have filed Lynparza (olaparib) for use in BRCA-mutated, HER2-negative early breast cancer in patients who have already been treated with chemotherapy either before or after surgery and are at high risk of the disease coming back.

FDA 111
article thumbnail

Decentralized format can help elevate trial inclusivity: Science 37

Outsourcing Pharma

An expert from the decentralized clinical trial solutions provider discusses how the virtual format and technology can help improve study representation.

82
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Ep. 016 How Biotech and Pharma Companies are Using Technology to Improve CX – Jennifer Ginest and Robert Schildt of Biohaven Pharmaceuticals

Pharma Marketing Network

Tune in to this episode of the Pharma Marketing Podcast to hear from our guest, Robert Schildt, Senior Director of Go-To-Market Innovation at Biohaven Pharmaceuticals and Jennifer Ginest, Digital Marketing Manager of PMN discuss how digital is being used to engage and personalize the CX experience in pharma.

52
article thumbnail

Pandemic-era burnout, short-staffing has more nurses eyeing the door, survey says

Fierce Healthcare

Pandemic-era burnout, short-staffing has more nurses eyeing the door, survey says. dmuoio. Fri, 12/03/2021 - 14:22.

141
141
article thumbnail

Novartis takes aim at risky Parkinson’s target with $1.5bn UCB deal

pharmaphorum

Novartis has licensed a potential drug for Parkinson’s from Belgium’s UCB that it thinks could be the first oral, disease-modifying drug for the disease – if it can avoid the fate of earlier drugs in the class. The drug – called UCB0599 – targets a protein called alpha synuclein that tends to get misfolded and accumulates into clumps in the brains of Parkinson’s patients, and is thought to damage neurons – somewhat analogous to amyloid and tau proteins in Alzheimer’s dise

article thumbnail

AI-based blood analysis tool geared toward decentralized diagnostics

Outsourcing Pharma

With the release of its new Sight OLO artificial intelligence based blood analyzer, Sight Diagnostics hopes to offer DCTs reliable, easy-to-use testing.

76
article thumbnail

Market Intelligence for Emerging Markets

Fuld

Why is market intelligence important? Market intelligence is important for any company – whether that company is seeking growth or just working to maintain share. Markets are dynamic and any number of asymmetric and unknown forces can be at play. Typically, clients are looking for market insight when they are about to make an investment, forge a partnership or change their go-to market strategy.

article thumbnail

AMA: Medicare physician fee schedule spending dropped nearly $14B last year due to COVID-19

Fierce Healthcare

AMA: Medicare physician fee schedule spending dropped nearly $14B last year due to COVID-19. rking. Fri, 12/03/2021 - 12:25.

141
141
article thumbnail

Pharma pledges rapid response to Omicron COVID variant

pharmaphorum

With governments around the world announcing measures to curb the new B.1.1.529 variant of COVID-19 – now christened Omicron – leading vaccine manufacturers have said they are poised to develop new shots if needed. News of the new variant emerged last week, and has resulted in travel bans being imposed on various African countries by the US, EU and UK, among others.

Vaccines 111
article thumbnail

Decentralized trials dramatically transforming clinical research: ICON

Outsourcing Pharma

An expert from the contract research organization discusses the impact decentralized trials have had on the industry, and how that transformation is likely to continue.

64
article thumbnail

2022 membership for microbiologists and those working alongside them

Pharmig

It’s now time for Pharmig to look forward into 2022 and update our event portfolio. The post 2022 membership for microbiologists and those working alongside them appeared first on Pharmig.

52
article thumbnail

PCMA pulls lawsuit over rebate disclosure rule after reaching deal with Biden admin

Fierce Healthcare

PCMA pulls lawsuit over rebate disclosure rule after reaching deal with Biden admin. rking. Thu, 12/02/2021 - 16:20.

140
140
article thumbnail

Trial closes gap between Bayer’s Nubeqa and rivals in prostate cancer

pharmaphorum

Bayer’s Nubeqa is making headway as a treatment for castration-resistant prostate cancer (CRPC), but could be on track to expand the eligible patient population for the drug thanks to new phase 3 data. Just released results from the ARASENS trial show that adding Nubeqa (darolutamide) to docetaxel chemotherapy and androgen deprivation therapy (ADT) to switch off testosterone production helps men with castration-sensitive prostate cancer (CSPC).

article thumbnail

Automating safety processes can benefit DCTs: Pharmasol

Outsourcing Pharma

A leader from the pharmacovigilance solutions firm discusses the ins and outs managing safety documentation and offers advice on how to deal with them.

article thumbnail

Emmes Announces Completion of Third ACTT Clinical Trial for COVID-19

Pharma Mirror

Rockville, Emmes today announced that it conducted the data and statistical analysis for the third iteration of the Adaptive COVID-19 Treatment Trial (ACTT-3), using its proprietary Advantage eClinical system. The ACTT-3 trial assessed the efficacy and safety of interferon beta-1a plus remdesivir compared to remdesivir alone in hospitalized adults with COVID-19.

article thumbnail

HHS: Telehealth use in Medicare increased 63-fold last year with behavioral health increasing the most

Fierce Healthcare

HHS: Telehealth use in Medicare increased 63-fold last year with behavioral health increasing the most. rking. Fri, 12/03/2021 - 16:14.

137
137
article thumbnail

15 traits of effective bosses and how to catalyse your team

pharmaphorum

Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional and global life science communications to offer some little tips for enjoying a big business career. This post looks at people manager effectiveness and how to boost team and co-worker engagement. It’s that special time in the annual corporate lifecycle: year-end performance reviews are being conducted around the globe, employee ratings allocated, calibrated and translated into salary increa